# Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

> **NCT04731376** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Emory University** · enrollment: 56 (actual)

## Conditions studied

- Hypogonadism
- Malignant Urinary System Neoplasm
- Urinary System Disorder
- Urinary System Neoplasm

## Interventions

- **OTHER:** Best Practice
- **PROCEDURE:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **DRUG:** Testosterone Cypionate

## Key facts

- **NCT ID:** NCT04731376
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-01-25
- **Primary completion:** 2024-11-26
- **Final completion:** 2026-12-31
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2026-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04731376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04731376, "Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04731376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*